Novartis AG
$123.12-1.88Market Cap
$267.9B
Global Rank
#54
All-Time High
$277.6B
2026-07-28
Total Growth
+0%
since 2026
Market Cap Context
- Larger than 85% of the 367 companies we track (globally).
- Equivalent to 25.7% of Switzerland's GDP (2025 data).
- Just above: #53 China Construction Bank Corporation ($275.8B)
- Just below: #55 Mitsubishi UFJ Financial Group, Inc. ($265.2B)
- Best year: 1997 (+64%). Worst year: 2001 (-15%).
Novartis AG Financial Breakdown (FY 2025)
Source: Yahoo Finance โ NOVN.SW annual filings (2025) โ$56.7B revenue ยท $17.6B operating income ยท $14.0B net income
- โOperating margin: 31.1% on $56.7B in revenue.
- โR&D is 19.8% of revenue ($11.2B).
- โNet income margin: 24.7% โ $14.0B in profit.
- โFree cash flow: $15.2B (26.9% of revenue).
Cost / Operating Expenses
Total operating expenses $39.0B
Total
$38.1B
Capital Expenditures
$3.9B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$15.2B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Fundamentals (TTM)
Data: Financial Modeling PrepP/E
โ
EPS
โ
Net margin
โ
ROE
โ
Dividend yield
โ
Debt / Equity
โ
About Novartis AG
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis AG Market Cap History (2026โ2026)
Novartis AG vs Sector Peers by Market Cap
Compare Novartis AG
Ranking History
| Year | Market Cap | Rank | YoY Change |
|---|---|---|---|
| 2026 | $267.9B | #54(โ3) | +17.9% |
| 2025 | $227.3B | #57(โ6) | +28.0% |
| 2024 | $177.6B | #63(โ3) | +8.4% |
| 2023 | $163.8B | #60(โ8) | +11.9% |
| 2022 | $146.3B | #52(โ19) | +8.8% |
| 2021 | $134.5B | #71(โ10) | -0.1% |
| 2020 | $134.7B | #61(โ25) | -5.4% |
| 2019 | $142.4B | #36(โ5) | +28.5% |
| 2018 | $110.8B | #41(โ4) | +6.5% |
| 2017 | $104.0B | #45(โ4) | +16.0% |
| 2016 | $89.6B | #41(โ14) | -10.7% |
| 2015 | $100.4B | #27(โ2) | -2.9% |
| 2014 | $103.4B | #25(โ14) | +34.9% |
| 2013 | $76.6B | #39(โ2) | +29.4% |
| 2012 | $59.2B | #37(โ2) | +12.9% |
| 2011 | $52.5B | #35(โ1) | +2.7% |
| 2010 | $51.1B | #36(โ8) | +0.8% |
| 2009 | $50.7B | #28(โ6) | +13.9% |
| 2008 | $44.5B | #22(โ16) | -12.1% |
| 2007 | $50.6B | #38(โ11) | -9.5% |
| 2006 | $55.9B | #27(โ8) | +3.7% |
| 2005 | $53.9B | #19(โ6) | +23.1% |
| 2004 | $43.8B | #25(โ1) | +4.2% |
| 2003 | $42.0B | #24(โ4) | +14.0% |
| 2002 | $36.9B | #20(โ3) | -14.5% |
| 2001 | $43.1B | #23(โ3) | -15.0% |
| 2000 | $50.7B | #26(โ7) | +24.5% |
| 1999 | $40.7B | #33(โ11) | -12.0% |
| 1998 | $46.3B | #22(โ6) | +15.4% |
| 1997 | $40.1B | #16(โ4) | +63.8% |
| 1996 | $24.5B | #20(โ4) | +45.2% |
| 1995 | $16.9B | #24 |
Other Healthcare Companies
FAQ
What is Novartis AG's market cap?
Novartis AG (NOVN.SW) has a market capitalization of $267.9B, making it the #54 largest company in the world by market cap.
What was Novartis AG's highest market cap?
Novartis AG's all-time high market cap was $277.6B, reached in 2026-07-28. Its highest rank was #54 in 2026.
What sector is Novartis AG in?
Novartis AG is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in Switzerland.
How has Novartis AG's market cap changed over time?
Novartis AG has been tracked since 2026. Its market cap has grown by 0% from $267.9B in 2026 to $267.9B today.